Steris PLC (NYSE:STE) Director Richard Martin Steeves sold 5,960 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $150.75, for a total value of $898,470.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Richard Martin Steeves also recently made the following trade(s):
- On Wednesday, December 4th, Richard Martin Steeves sold 5,854 shares of Steris stock. The stock was sold at an average price of $153.77, for a total value of $900,169.58.
Shares of NYSE STE traded up $1.99 during mid-day trading on Wednesday, reaching $154.07. The company had a trading volume of 471,410 shares, compared to its average volume of 469,005. The company has a current ratio of 2.41, a quick ratio of 1.86 and a debt-to-equity ratio of 0.73. The firm has a 50 day simple moving average of $145.59 and a two-hundred day simple moving average of $145.58. The stock has a market cap of $12.81 billion, a P/E ratio of 31.51 and a beta of 0.89. Steris PLC has a 52-week low of $99.14 and a 52-week high of $156.66.
Steris (NYSE:STE) last announced its quarterly earnings results on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Steris had a net margin of 11.59% and a return on equity of 16.15%. The firm had revenue of $736.84 million during the quarter, compared to analysts’ expectations of $717.79 million. During the same period in the previous year, the company earned $1.10 earnings per share. Steris’s quarterly revenue was up 8.5% compared to the same quarter last year. On average, equities analysts expect that Steris PLC will post 5.6 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Tuesday, November 26th will be issued a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 0.96%. The ex-dividend date is Monday, November 25th. Steris’s payout ratio is 30.27%.
Separately, ValuEngine downgraded Steris from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $148.20.
Institutional investors and hedge funds have recently bought and sold shares of the company. Man Group plc boosted its position in shares of Steris by 76.0% in the 3rd quarter. Man Group plc now owns 182,271 shares of the medical equipment provider’s stock valued at $26,336,000 after purchasing an additional 78,728 shares during the period. Signet Financial Management LLC purchased a new stake in Steris in the third quarter valued at approximately $2,506,000. Select Equity Group L.P. purchased a new stake in Steris in the third quarter valued at approximately $19,564,000. Squarepoint Ops LLC boosted its holdings in shares of Steris by 396.3% in the third quarter. Squarepoint Ops LLC now owns 60,906 shares of the medical equipment provider’s stock valued at $8,800,000 after acquiring an additional 48,635 shares during the period. Finally, Voloridge Investment Management LLC acquired a new stake in shares of Steris in the third quarter valued at approximately $4,255,000. Institutional investors and hedge funds own 86.77% of the company’s stock.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Further Reading: Investing in Blue-Chip Stocks
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.